Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04099992 · ClinicalTrials.gov registry record · NA

Mindfulness in Chronic Kidney Disease

A NA study of Chronic Kidney Diseases, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT04099992 is a NA study of Chronic Kidney Diseases that is actively recruiting participants, run by Emory University. The registered enrollment target is 150 participants, below the 443-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04099992, a NA study of Chronic Kidney Diseases, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study will test whether mindfulness meditation (MM) improves sympathetic function in chronic kidney disease (CKD) and whether transcutaneous vagus nerve stimulation (tVNS) optimizes the sympatho-inhibitory effects of mindfulness meditation (MM) and restores autonomic balance in CKD patients.

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness-based stress reduction (MBSR)
  • BEHAVIORAL Health enhancement program (HEP)
  • DEVICE Transcutaneous Vagus Nerve Stimulation (tVNS)
  • DEVICE Sham-transcutaneous Vagus Nerve Stimulation (tVNS)

Study Locations (1)

Georgia

  • Atlanta VA Medical Center - Atlanta

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2019-09-20
Est. Completion 2026-09
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04099992

The ClinicalTrials.gov registry entry for NCT04099992 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 443-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (66% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 4 interventions - of which Mindfulness-based stress reduction (MBSR) is the first listed.

NCT04099992 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04099992 about?

NCT04099992 is a clinical study titled "Mindfulness in Chronic Kidney Disease". This study will test whether mindfulness meditation (MM) improves sympathetic function in chronic kidney disease (CKD) and whether transcutaneous vagus nerve stimulation (tVNS) optimizes the sympatho-inhibitory effects of mindfulness meditation (MM) and restores autonomic balance in CKD patients.

What is the current status of trial NCT04099992?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2019-09-20. Estimated completion is 2026-09.

What conditions does trial NCT04099992 study?

This clinical trial studies the following conditions: Chronic Kidney Diseases.

What interventions are being tested in trial NCT04099992?

The interventions under investigation include: Mindfulness-based stress reduction (MBSR) (BEHAVIORAL), Health enhancement program (HEP) (BEHAVIORAL), Transcutaneous Vagus Nerve Stimulation (tVNS) (DEVICE), Sham-transcutaneous Vagus Nerve Stimulation (tVNS) (DEVICE).

Who is sponsoring clinical trial NCT04099992?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04099992 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.